Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Carbamazepine caused hair loss and skin eruptions in a woman, which improved after stopping the medication.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

The conclusion is that using light-sheet fluorescence microscopy with a special solution can effectively create detailed 3D images of human skin for dermatological research.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

Some hair loss drugs can cause a unique type of hair loss that resembles both psoriasis and alopecia.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Skin reactions to antidepressants are common but usually not serious and can be treated.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.